Skip to main content
    L

    Larimar Therapeutics Inc (LRMR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.00
    -0.02 (-0.66%)

    Market Cap: $313.73M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Larimar Therapeutics Inc (LRMR) Earnings: Report Dates and Results

    Updated Nov 11, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Larimar Therapeutics (LRMR) is expected to report earnings on Mar 17, 2027. In the quarter ended Sep 30, 2026, Larimar Therapeutics reported EPS of -$0.61, below the -$0.35 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    65%(26/40)
    Avg Surprise
    +5.72%

    Upcoming Estimates

    Reports Mar 17, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.38
    Range-$0.44 - -$0.33
    13 analysts
    Revenue Consensus
    N/A
    RangeN/A
    12 analysts

    Next Report

    LRMR has an expected report date of Mar 17, 2027.

    Earnings History

    Of the 40 quarters below that had an estimate, LRMR beat 26, missed 13 and matched 1. The widest gap in the table came in the quarter ended Sep 30, 2026, when EPS landed 74.29% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.61-$0.35-$0.41 - -$0.31-74.29%MissN/A86 up, 0 downNov 11, 2026
    Jun 30, 2026-$0.30-$0.39-$0.48 - -$0.33+23.08%BeatN/A8N/AAug 4, 2026
    Mar 31, 2026-$0.31-$0.59-$0.74 - -$0.40+47.46%BeatN/A50 up, 3 downMay 14, 2026
    Dec 31, 2025-$0.73-$0.49-$0.67 - -$0.41-48.98%MissN/A70 up, 3 downMar 19, 2026
    Sep 30, 2025-$0.61-$0.39-$0.50 - -$0.36-56.41%MissN/A86 up, 1 downNov 5, 2025
    Jun 30, 2025-$0.41-$0.49-$0.51 - -$0.46+16.33%BeatN/A71 up, 0 downAug 14, 2025
    Mar 31, 2025-$0.46-$0.41-$0.46 - -$0.35-12.20%MissN/A71 up, 3 downApr 30, 2025
    Dec 31, 2024-$0.45-$0.32-$0.45 - -$0.25-40.89%MissN/A101 up, 0 downMar 24, 2025
    Sep 30, 2024-$0.24-$0.37-$0.42 - -$0.29+35.14%BeatN/A110 up, 0 downOct 30, 2024
    Jun 30, 2024-$0.34-$0.32-$0.35 - -$0.26-6.25%MissN/A60 up, 0 downAug 7, 2024
    Mar 31, 2024-$0.27-$0.24-$0.25 - -$0.21-12.50%MissN/A40 up, 0 downMay 9, 2024
    Dec 31, 2023-$0.30-$0.25-$0.28 - -$0.22-20.00%MissN/A50 up, 0 downMar 14, 2024
    Sep 30, 2023-$0.21-$0.23-$0.27 - -$0.20+8.70%BeatN/A50 up, 0 downNov 14, 2023
    Jun 30, 2023-$0.19-$0.21-$0.27 - -$0.15+9.52%BeatN/A50 up, 0 downAug 10, 2023
    Mar 31, 2023-$0.15-$0.25-$0.26 - -$0.23+40.00%BeatN/A40 up, 0 downMay 15, 2023
    Dec 31, 2022-$0.21-$0.37-$0.78 - -$0.21+43.24%BeatN/A50 up, 0 downMar 14, 2023
    Sep 30, 2022-$0.37-$0.42-$0.77 - -$0.20+11.90%BeatN/A40 up, 0 downNov 10, 2022
    Jun 30, 2022-$0.47-$0.57N/A+17.54%BeatN/AN/A0 up, 0 downAug 11, 2022
    Mar 31, 2022-$0.49-$0.51-$0.51 - -$0.51+3.92%BeatN/A20 up, 0 downMay 12, 2022
    Dec 31, 2021-$0.50-$0.72-$0.96 - -$0.43+30.56%BeatN/A3N/AMar 25, 2022
    Sep 30, 2021-$0.92-$0.66-$0.69 - -$0.60-39.39%MissN/A31 up, 0 downNov 12, 2021
    Jun 30, 2021-$0.79-$0.75-$0.78 - -$0.70-5.33%MissN/A3N/AAug 12, 2021
    Mar 31, 2021-$0.76-$0.86-$0.93 - -$0.80+11.63%BeatN/A2N/AMay 10, 2021
    Dec 31, 2020-$0.89-$0.70N/A-27.14%MissN/AN/AN/AMar 4, 2021
    Sep 30, 2020-$0.64-$2.28N/A+71.93%BeatN/AN/AN/ANov 10, 2020
    Jun 30, 2020-$1.21-$2.16N/A+43.98%BeatN/AN/AN/AAug 11, 2020
    Mar 31, 2020-$1.20-$2.28N/A+47.37%BeatN/AN/AN/AMay 8, 2020
    Dec 31, 2019-$2.28-$2.28N/A0.00%In lineN/AN/AN/AMar 5, 2020
    Sep 30, 2019-$2.88-$3.20N/A+10.00%BeatN/AN/AN/ANov 6, 2019
    Jun 30, 2019-$3.84-$4.38N/A+12.33%BeatN/AN/AN/AAug 8, 2019
    Mar 31, 2019-$4.20-$5.09N/A+17.49%BeatN/AN/AN/AMay 9, 2019
    Dec 31, 2018-$4.68-$5.26N/A+11.03%BeatN/AN/AN/AMar 11, 2019
    Sep 30, 2018-$4.92-$5.64N/A+12.77%BeatN/AN/AN/ANov 7, 2018
    Jun 30, 2018-$6.84-$7.08N/A+3.39%BeatN/AN/AN/AAug 7, 2018
    Mar 31, 2018-$6.96-$6.18N/A-12.62%MissN/AN/AN/AMay 8, 2018
    Dec 31, 2017-$5.76-$6.84N/A+15.79%BeatN/AN/AN/AMar 6, 2018
    Sep 30, 2017-$5.52-$6.92N/A+20.23%BeatN/AN/AN/ANov 7, 2017
    Jun 30, 2017-$5.88-$6.24N/A+5.77%BeatN/AN/AN/AAug 8, 2017
    Mar 31, 2017-$5.76-$5.21N/A-10.56%MissN/AN/AN/AMay 9, 2017
    Dec 31, 2016-$4.56-$6.03N/A+24.38%BeatN/AN/AN/AMar 9, 2017
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$2.21, after -$1.30 the year before. It was -$25.44 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$2.21N/A
    Dec 31, 2024-$1.30N/A
    Dec 31, 2023-$0.85N/A
    Dec 31, 2022-$1.54N/A
    Dec 31, 2021-$2.97N/A
    Dec 31, 2020-$3.94N/A
    Dec 31, 2019-$13.20N/A
    Dec 31, 2018-$23.40N/A
    Dec 31, 2017-$22.92N/A
    Dec 31, 2016-$25.44N/A

    Frequently Asked Questions About LRMR

    When is Larimar Therapeutics's next earnings date?

    Larimar Therapeutics's next earnings report is expected for Mar 17, 2027.

    Did LRMR beat earnings estimates last quarter?

    No. Larimar Therapeutics reported EPS of -$0.61 for the quarter ended Sep 30, 2026, below the -$0.35 estimate by 74.29%.

    What EPS do analysts expect from LRMR next quarter?

    The consensus EPS estimate for Larimar Therapeutics for the quarter ending Dec 31, 2026 is -$0.38 from 13 analysts, with estimates from -$0.44 to -$0.33.

    How often does LRMR beat earnings estimates?

    Larimar Therapeutics beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -18.24%.